DalsnaFinance › Analyst accuracy › Truist Securities › AMGN target
Truist Financial Boosts Amgen (NASDAQ:AMGN) Price Target to $362.00
Truist Financial increased their price objective on shares of Amgen from $340.00 to $362.00 and gave the company a 'hold' rating
A fact about what Truist Securities published, as reported by MarketBeat, not a recommendation from Dalsna Finance; Truist Securities is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.